Technical analysis of BioRestorative Therapies, Inc. (BRTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100.
Price Performance
| 1 month | -40.14% |
| 3 months | -68.86% |
| Year-to-date | -89.19% |
| 1 year | -91.08% |
| 3 years | -92.59% |
| 5 years | -99.00% |
52-Week Range
| 52-week High | $34.60 |
| 52-week Low | $2.55 |
| Avg Volume (90d) | 359K |
Technical Indicators
| SMA 50 | $4.64 |
| SMA 200 | $9.61 |
| 30-day Volatility (annualised) | 104.5% |
| Price vs SMA 50 | -45.0% |
| Price vs SMA 200 | -73.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $30.80 | |
| 2025-11 | $21.60 | -29.9% |
| 2025-12 | $23.60 | +9.3% |
| 2026-01 | $22.80 | -3.4% |
| 2026-02 | $4.57 | -80.0% |
| 2026-03 | $5.44 | +19.0% |
| 2026-04 | $4.50 | -17.3% |
| 2026-05 | $9.56 | +112.4% |
| 2026-06 | $7.52 | -21.3% |
| 2026-07 | $4.09 | -45.6% |
| 2026-08 | $4.05 | -1.0% |
| 2026-09 | $2.55 | -37.0% |
Price
| Price | $2.55 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.76 |
| EV / EBITDA | -0.07 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 2.35 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -69.34 |